CrushSCI.com
114.1Average days
98Median days
37Fastest days
254Longest days
1382025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

54 days

Disseminated Lymphoplasmacytic Lymphoma to the Sympathetic Chain Causing VT Storm

Authors
Ban Dodin; R. Cody Simon; Sonali M. Smith; Gaurav A. Upadhyay; Zaid Aziz; Tamar S. PolonskyShow moreShow less
Affiliations
University of Chicago Medicine, Chicago, Illinois, USAShow moreShow less
Source PDF DOI Publisher page
82 days

Fatal Coronary and Mesenteric Vasculopathy With Immune Checkpoint Inhibitor Therapy

Authors
Aleksandra Abrahamowicz; Roberta Florido; Drew Ferguson; Fred Clayton; Monica P. Revelo; Anees DaudShow moreShow less
Affiliations
Division of Cardiovascular Medicine, University of Utah, Salt Lake City, Utah, USA; Department of Pathology, University of Utah, Salt Lake City, Utah, USAShow moreShow less
Source PDF DOI Publisher page
98 days

High-Sensitivity Cardiac Troponin T and I Discordance in Patients Receiving Immune Checkpoint Inhibitors

Authors
Anis Ismail; Alexi Vasbinder; Bobby Bobby; McKenna de Bever; Aidan Vosooghi; Valeria Pena-Valentin; Lihua Shu; Sujay Kalathoor; Ramya Elangovan; Rachel Jones; Julia Skibniewska; Ian Pizzo; Tonimarie Catalan; Theresa Farhat; Pennelope Kunkle; Monika Leja; Salim S. HayekShow moreShow less
Affiliations
Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA; School of Nursing, University of Washington, Seattle, Washington, USA; John Sealy School of Medicine, University of Texas Medical Branch, Galveston, Texas, USA; Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA; Division of Cardiology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USAShow moreShow less
Source PDF DOI Publisher page
254 days

Fibrotic Rewiring of CD8+ T Cells by Doxorubicin Drives Pathological Remodeling of Cardiac Extracellular Matrix

Authors
Abraham L. Bayer; Ramona Emig; Celina Kley; Maria Antonia Zambrano; Zachary L. Robbe; Jose Max Narvaez-Paliza; Sanam Alilou; Sarah Powers; Jenica N. Upshaw; Aarti Asnani; Pilar AlcaideShow moreShow less
Affiliations
Tufts University School of Medicine, Boston, Massachusetts, USA; Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, USA; Department of Cardiology, German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg, Internal Medicine III, Heidelberg University Hospital, Heidelberg, Germany; Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, Massachusetts, USAShow moreShow less
Source PDF DOI Publisher page
39 days

Statin Use Attenuates Leuprolide-Associated Coronary Atherosclerosis Progression

Authors
Adithya K. Yadalam; Chang Liu; Marly van Assen; Nikhil T. Sebastian; Vishal R. Dhere; Bruce W. Hershatter; Pretesh R. Patel; Ashesh B. Jani; Carlo N. De Cecco; Stephanie M. Cantu; Anant Mandawat; Sagar A. PatelShow moreShow less
Affiliations
Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA; Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia, USA; Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia, USA; Winship Cancer Institute of Emory University, Atlanta, Georgia, USA; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia, USAShow moreShow less
Source PDF DOI Publisher page
103 days

Sacubitril/Valsartan and Right Ventricular and Diastolic Function During Breast Cancer Therapy

Authors
Mari Nordbø Gynnild; Albulena Mecinaj Lilleaasen; Torgeir Wethal; Even O. Jakobsen; Victoria Vinje-Jakobsen; Siri Lagethon Heck; Stian Larsen; Assami Rösner; Havard Dalen; Torbjørn Omland; Geeta Gulati; Espen HolteShow moreShow less
Affiliations
K.G. Jebsen Center for Cardiac Biomarkers, Institute of Clinical Medicine, University of Oslo, Norway; Department of Cardiology and Cardiothoracic Surgery, St Olavs University Hospital, Trondheim, Norway; Department of Circulation and Medical Imaging, Faculty of Medicine and Health Science, NTNU – Norwegian University of Science and Technology, Trondheim, Norway; Department of Cardiology, Division of Medicine, Akershus University Hospital, Norway; Stroke Unit, Clinic of Medicine, St Olavs University Hospital, Trondheim, Norway; Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Science, NTNU – Norwegian University of Science and Technology, Trondheim, Norway; Department of Diagnostic Imaging, Akershus University, Hospital, Lørenskog, Norway; Department of Cardiology, Stavanger University Hospital, Stavanger, Norway; Department of Cardiology, Division of Cardiothoracic and Respiratory Medicine, University Hospital of North Norway, Tromsø, Norway; Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway; Department of Medicine, Levanger Hospital, Nord-Trøndelag Hospital Trust, Levanger, Norway; Department of Cardiology, Division of Medicine, Oslo University Hospital, Ullevål, NorwayShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does JACC: CardioOncology take to review a manuscript?

As of 2026-11-19, CrushSCI has 15 complete review records for JACC: CardioOncology. The fastest paper went from submission to acceptance in 37 days (A Bleeding Risk Score for Cancer-Associated Venous Thromboembolism in Patients Receiving Direct Oral Anticoagulants, received 2026-03-29, accepted 2026-05-05); the slowest took 254 days. The average is 114.1 days and the median is 98 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.